Top Stories
Image source: Getty Images Since the start of the year, the S&P…
BioVaxys Technology Corp. is developing its patented DPX™ platform to address the challenges of lipid nanoparticles (LNPs) in mRNA vaccine delivery. Learn how DPX improves stability, immune responses, and manufacturing economics as the mRNA vaccine market projects $48 billion growth by 2030.
Image source: Getty Images It’s possible to be a brilliant growth…
Image source: Getty Images GlobalData (LSE: DATA) is an AIM-listed UK…
Image source: Getty Images What’s the best way to go about…
Image source: Rolls-Royce plc Anyone who decided to buy Rolls-Royce (LSE:RR)…
Investments
Investment in large-scale wind and solar in Australia has reached its highest…
Economy Insights
National News
Image source: Getty Images Since the start of the year, the S&P 500 is up a measly 2%. By contrast, our own FTSE 100 index of leading…
Image source: Getty Images It’s possible to be a brilliant growth share AND a dividend superstar. I’d argue that the London Stock Exchange Group (LSE: LSEG) has combined both…
Image source: Getty Images GlobalData (LSE: DATA) is an AIM-listed UK stock that doesn’t get too much mainstream coverage. Currently at 151p, it’s down 33% over the…
Image source: Getty Images What’s the best way to go about building up the biggest passive income pot we can in an ISA? Today’s Stocks and Shares…
Image source: Rolls-Royce plc Anyone who decided to buy Rolls-Royce (LSE:RR) shares five years ago has done very well. The share price is up 677% since June…
Image source: Getty Images How much would a UK investor need in a tax-efficient Stocks and Shares ISA to retire comfortably? This is a question that popped…